Form D · Pharmaceuticals
Pharmazz, Inc.
Willowbrook, IL · CIK 0001729963
Offering snapshot reported Jul 28, 2026 · SEC filing
- Reported sold
- $250K Offering amount: $3.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2026 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jun 11, 2025 | Initial | $10,037,500 | No comparison | 1 | SEC filing |
| Aug 30, 2024 | Initial | $7,500,000 | No comparison | 1 | SEC filing |
| Feb 16, 2024 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Nov 2, 2023 | Initial | $450,000 | No comparison | 3 | SEC filing |
| May 18, 2023 | Initial | $2,300,000 | No comparison | 16 | SEC filing |
| May 18, 2023 | Amendment | $5,450,000 | $5,200,000vs Apr 29, 2021 | 28 | SEC filing |
| Apr 29, 2021 | Initial | $250,000 | No comparison | Not reported | SEC filing |
| Mar 3, 2020 | Initial | $1,405,500 | No comparison | 1 | SEC filing |
| Nov 14, 2019 | Amendment | $3,691,000 | $1,495,000vs Aug 7, 2019 | 23 | SEC filing |
| Aug 7, 2019 | Initial | $2,196,000 | No comparison | 22 | SEC filing |
| Aug 6, 2019 | Amendment | $723,603 | $424,304vs Feb 1, 2018 | 16 | SEC filing |
| Feb 1, 2018 | Initial | $299,299 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592347
Source: Form D, filed Jul 28, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Costello | Executive |
| Anil Gulati | Director, Executive |
| Sunil Gulati | Executive |
| Jane Kiernan | Director |
| Dharminder Marwah | Director, Executive |
| James Mc Connell | Director |
| James Mc Donnell | Director |
| Atul Raut | Director |
| Guru Reddy | Executive |
| Ajit Srimal | Director, Executive |
| Daniel Stauder | Executive |
| Gaylord Toft | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
50 W 75 Th St Ste 105
Willowbrook, IL, 60527
Phone: 630-780-6087
Willowbrook, IL, 60527
Phone: 630-780-6087